In colorectal cancer tissues, carnitine palmitoyltransferase 2 (CPT2) expression is downregulated, activating the ROS/Wnt/β-catenin pathway and inducing oxaliplatin resistance in colorectal cancer [94]. Here, CPT2 is linked to colorectal cancer.